|
G |
Abca8 |
ATP binding cassette subfamily A member 8 |
multiple interactions |
ISO |
verlukast inhibits the reaction [ABCA8 protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:12379217 |
|
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
ISO |
verlukast results in decreased activity of ABCB11 protein verlukast inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity |
ISO |
verlukast results in decreased activity of ABCB1 protein |
CTD |
PMID:16316932 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases activity |
ISO EXP |
[verlukast affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [verlukast binds to and results in decreased activity of ABCC1 protein] inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of Daunorubicin; [verlukast results in decreased activity of ABCC1 protein] which results in increased susceptibility to Arsenic Trioxide; verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein affects the transport of Bilirubin]; verlukast inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione]; verlukast inhibits the reaction [ABCC1 protein mutant form results in increased transport of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Arsenic Trioxide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Mercuric Chloride]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to sodium arsenate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; verlukast inhibits the reaction [ABCC1 protein results in decreased uptake of and results in decreased susceptibility to Arsenic Trioxide]; verlukast inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC1 protein results in increased export of Daunorubicin]; verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein results in increased export of Methylmercury Compounds]; verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of zearalenol]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of Zearalenone]; verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein]; verlukast inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] [Epinephrine co-treated with [verlukast results in decreased activity of ABCC1 protein]] results in increased abundance of Glutathione Disulfide; [verlukast results in decreased activity of ABCC1 protein] inhibits the reaction [Arsenates results in increased export of Glutathione]; [verlukast results in decreased activity of ABCC1 protein] which promotes the reaction and affects the abundance of Epinephrine metabolite; [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine |
CTD |
PMID:10025956 PMID:10685512 PMID:11331074 PMID:12893836 PMID:15041478 PMID:15180633 PMID:15245331 PMID:15451006 PMID:15694464 PMID:15804283 PMID:15916776 PMID:16004972 PMID:16049968 PMID:16101123 PMID:16156793 PMID:18204840 PMID:18336795 PMID:18633430 PMID:19053318 PMID:19647055 PMID:21728338 PMID:23052202 PMID:23542460 PMID:25058526 PMID:26454883 PMID:32915249 PMID:34896433 PMID:35972551 More...
|
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases activity multiple interactions |
ISO EXP |
verlukast results in decreased activity of ABCC2 protein [verlukast results in decreased activity of ABCC2 protein] which results in decreased secretion of Resveratrol metabolite; ABCC2 protein affects the reaction [verlukast results in decreased secretion of Chenodeoxycholic Acid] verlukast results in decreased activity of ABCC2 protein; verlukast results in decreased activity of ABCC2 protein modified form [verlukast results in decreased activity of ABCC2 protein] which results in decreased export of Topotecan; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylhypaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylmesaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of hypaconitine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of mesaconitine; [verlukast results in decreased activity of ABCC2 protein] which results in increased uptake of Vinblastine; verlukast inhibits the reaction [[Adenosine Triphosphate co-treated with ABCC2 protein] results in increased uptake of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Paclitaxel]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of Leukotriene C4]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of zearalenol]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of Zearalenone]; verlukast inhibits the reaction [Bucladesine results in increased activity of ABCC2 protein] |
CTD |
PMID:15451006 PMID:15729621 PMID:15904671 PMID:16316932 PMID:19070657 PMID:19505989 PMID:19647055 PMID:19952419 PMID:20089784 PMID:20457140 PMID:21262925 PMID:23200901 PMID:25844889 PMID:27676153 PMID:29052767 PMID:32003934 More...
|
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
verlukast inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of Leukotriene C4]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of zearalenol] |
CTD |
PMID:19647055 PMID:27676153 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions decreases activity |
ISO |
verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein results in decreased susceptibility to Thioguanine]; verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC4 protein]; verlukast inhibits the reaction [Quercetin results in increased activity of ABCC4 protein] verlukast results in decreased activity of ABCC4 protein |
CTD |
PMID:16004972 PMID:16156793 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
multiple interactions |
ISO |
verlukast inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16156793 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
verlukast inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] |
CTD |
PMID:12869632 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
verlukast binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
verlukast promotes the reaction [benzyl isothiocyanate results in increased activity of and results in increased cleavage of CASP3 protein] |
CTD |
PMID:33880814 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
ISO |
verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL11 mRNA] |
CTD |
PMID:12794006 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
multiple interactions |
ISO |
verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL12 mRNA] |
CTD |
PMID:12794006 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] |
CTD |
PMID:12794006 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
verlukast promotes the reaction [arsenic trioxide results in decreased activity of CYP1A1 protein] |
CTD |
PMID:12490585 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
multiple interactions |
ISO |
alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [verlukast binds to and results in decreased activity of CYSLTR1 protein]; verlukast binds to and results in decreased activity of CYSLTR1 protein; verlukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; verlukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] verlukast binds to and results in decreased activity of CYSLTR1 protein; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] |
CTD |
PMID:8014876 PMID:8384568 PMID:10391245 PMID:10851239 PMID:11432448 PMID:11705452 PMID:12629151 PMID:14718577 More...
|
|
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
multiple interactions |
ISO |
verlukast binds to and results in decreased activity of CYSLTR2 protein; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR2 protein] |
CTD |
PMID:10851239 |
|
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
|
|
G |
Epx |
eosinophil peroxidase |
multiple interactions |
ISO |
verlukast inhibits the reaction [Ovalbumin results in increased expression of EPX protein] |
CTD |
PMID:12794006 |
|
NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
verlukast binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
verlukast binds to and results in decreased activity of ESR2 protein |
CTD |
PMID:25752796 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
verlukast promotes the reaction [FASL protein results in decreased abundance of Glutathione] |
CTD |
PMID:17724027 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
[verlukast binds to and results in decreased activity of ABCC1 protein] inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein] |
CTD |
PMID:21728338 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
verlukast inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide] |
CTD |
PMID:15999103 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO EXP |
verlukast inhibits the reaction [Ovalbumin results in increased expression of IL13 mRNA] verlukast inhibits the reaction [IL13 protein results in increased expression of MUC5AC protein] |
CTD |
PMID:12654629 PMID:12794006 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
verlukast inhibits the reaction [Bleomycin results in increased expression of IL1B protein] |
CTD |
PMID:17118201 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
verlukast inhibits the reaction [Ovalbumin results in increased expression of IL4 mRNA] |
CTD |
PMID:12794006 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
verlukast promotes the reaction [benzyl isothiocyanate results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:33880814 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
verlukast promotes the reaction [benzyl isothiocyanate results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:33880814 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
verlukast inhibits the reaction [Bleomycin results in increased activity of MPO protein]; verlukast inhibits the reaction [Ovalbumin results in increased expression of MPO protein] |
CTD |
PMID:12794006 PMID:17118201 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO EXP |
verlukast inhibits the reaction [Ovalbumin results in increased expression of MUC5AC mRNA]; verlukast inhibits the reaction [Ovalbumin results in increased expression of MUC5AC protein] verlukast inhibits the reaction [IL13 protein results in increased expression of MUC5AC protein]; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC mRNA]; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC protein] |
CTD |
PMID:12654629 PMID:12794006 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
ISO |
verlukast inhibits the reaction [SLC22A8 protein results in increased uptake of Enalaprilat] |
CTD |
PMID:33007874 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
verlukast inhibits the reaction [Bleomycin results in increased expression of TNF protein] |
CTD |
PMID:17118201 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
ISO |
verlukast inhibits the reaction [UGT1A1 protein results in increased glucuronidation of anhydroicaritin] |
CTD |
PMID:30237061 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|